NCT00525967 Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain Status UNKNOWN Phase PHASE2/PHASE3
NCT00524407 Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy Status COMPLETED Phase PHASE4
NCT00523380 Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00523094 Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure Status SUSPENDED Phase N/A
NCT00520364 In Vitro Fertilization and Pregnancy After Use of Chemotherapy Status TERMINATED Phase N/A
NCT00520325 A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia Status WITHDRAWN Phase PHASE1
NCT00516451 Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00513656 A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain Status COMPLETED Phase PHASE2
NCT00512642 Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients Status COMPLETED Phase N/A
NCT00509691 Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy Status COMPLETED Phase PHASE1
NCT00506805 Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00505414 A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Status TERMINATED Phase PHASE3
NCT00504790 Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer Status COMPLETED Phase PHASE1
NCT00500292 A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00499733 Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer Status TERMINATED Phase EARLY_PHASE1
NCT00499499 A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors Status SUSPENDED Phase PHASE1
NCT00499291 Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors Status WITHDRAWN Phase NA